The STHLM3MRI trial

The study is further described in Nordström et al, BMJ Open 2018, "Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI".

Any questions can be e-mailed to Tobias Nordström or Anna Berglund.